Author | Bita Fakhri, MD, MPH | OncLive

Author | Bita Fakhri, MD, MPH

Articles

Dr. Fakhri on Ongoing Clinical Trials in CLL

February 18, 2020

Video

Bita Fakhri, MD, MPH, assistant professor of medicine in the Division of Hematology/Oncology at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses ongoing clinical trials in chronic lymphocytic leukemia (CLL).

Dr. Fakhri on the Use of PI3K Inhibitors in Relapsed/Refractory CLL

January 24, 2020

Article

Bita Fakhri, MD, MPH, assistant professor of medicine in the Division of Hematology/Oncology at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the use of PI3K inhibitors in relapsed/refractory chronic lymphocytic leukemia (CLL).

Dr. Fakhri on Tumor Lysis Syndrome Associated With Venetoclax/Obinutuzumab in CLL

January 16, 2020

Video

Bita Fakhri, MD, MPH, discusses concern over the tumor lysis syndrome that occurred in the CLL14 trial that looked at patients with previously untreated chronic lymphocytic leukemia.

Dr. Fakhri on Selecting the Optimal Treatment in CLL

January 10, 2020

Video

Bita Fakhri, MD, MPH, discusses considerations in selecting the optimal treatment in chronic lymphocytic leukemia.

x